Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel

Slideshow | ACC, NTPC, RIL among 10 stocks where brokerages see 6-86% upside

Here are 10 stocks where brokerages see 6-86 percent upside
Apr 27, 2020 / 12:16 PM IST
Sensex
Last week the Indian indices broke the 2 weeks winning momentum and ended lower amid volatility. Nifty Bank index fell over 5 percent and underperformed the frontliners. However, the BSE Midcap, Smallcap and Largecap indices shed between 1-3 percent. Here are 10 stocks where brokerages see 6-86 percent upside:
Alembic Pharma | Brokerage: ICICIdirect | Rating: Buy | Target: Rs 875 | LTP: Rs 759 | Upside: 15 percent
Alembic Pharma | Brokerage: ICICIdirect | Rating: Buy | Target: Rs 875 | LTP: Rs 759 | Upside: 15 percent
Jubilant FoodWorks | Brokerage: ICICI Securities | Rating: Buy | Target: Rs 1,800 | LTP: Rs 1,483 | Upside: 21 percent
Jubilant FoodWorks | Brokerage: ICICI Securities | Rating: Buy | Target: Rs 1,800 | LTP: Rs 1,483 | Upside: 21 percent
Bharti Infratel | Brokerage: ICICI Securities | Rating: Buy | Target: Rs 245 | LTP: Rs 152 | Upside: 61 percent
Bharti Infratel | Brokerage: ICICI Securities | Rating: Buy | Target: Rs 245 | LTP: Rs 152 | Upside: 61 percent
Federal Bank | Bank to buy additional stake of up to 4% in IDBI Federal Life Insurance from IDBI Bank. (Image: federalbank.co.in)
Federal Bank | Brokerage: Sharekhan | Rating: Buy | Target: Rs 80 | LTP: Rs 43 | Upside: 86 percent
ACC | Brokerage: KRChoksey | Rating: Buy | Target: Rs 1,415 | LTP: Rs 1,158 | Upside: 22 percent
ACC | Brokerage: KRChoksey | Rating: Buy | Target: Rs 1,415 | LTP: Rs 1,158 | Upside: 22 percent
Indian Metals & Ferro Alloys | India Ratings & Research (Ind-Ra) has downgraded the ratings from IND A /Stable/Ind A1 to IND A-/Stable/Ind A1. (Image: Moneycontrol)
Mishra Dhatu Nigam | Brokerage: ICICIdirect | Rating: Buy | Target: Rs 256 | LTP: Rs 203 | Upside: 26 percent
Q. The Drug controller general of India has allowed restricted use of Kaletra the combination of medications lopinavir and ritonavir, for treating those affected by novel coronavirus after the Indian Council of Medical Research (ICMR) sought an emergency approval for the same. Use of Kaletra was allowed based on the fact that previous studies suggested Kaletra, as effective in preventing SARS from maturing and replicating. It has already achieved good results in China and Japan in curing Coronavirus. What was Lopinavir and Ritonavir originally used for?
Caplin Point Laboratories | Brokerage: ICICIdirect | Rating: Buy | Target: Rs 500 | LTP: Rs 343 | Upside: 45 percent
ntpc
NTPC | Brokerage: Motilal Oswal | Rating: Buy | Target: Rs 148 | LTP: Rs 93 | Upside: 59 percent
The deal will help reduce RIL’s debt burden, which bulged due to the breakneck expansion of Jio and other businesses.
Reliance Industries | Brokerage: Emkay | Rating: Buy | Target: Rs 1,500 | LTP: Rs 1,417 | Upside: 6 percent. Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.
Tata Elxsi | Brokerage: KRChoksey | Rating: Buy | Target: Rs 831 | LTP: Rs 750 | Upside: 11 percent
Tata Elxsi | Brokerage: KRChoksey | Rating: Buy | Target: Rs 831 | LTP: Rs 750 | Upside: 11 percent
Rakesh Patil
first published: Apr 27, 2020 12:16 pm

stay updated

Get Daily News on your Browser
Sections